• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国V型成骨不全症患者的表型和基因型分析

Phenotype and genotype analysis of Chinese patients with osteogenesis imperfecta type V.

作者信息

Zhang Zeng, Li Mei, He Jin-Wei, Fu Wen-Zhen, Zhang Chang-Qing, Zhang Zhen-Lin

机构信息

Department of Orthopedic Surgery, Shanghai Jiao Tong University Affliated the Sixth People's Hospital, Shanghai, PR China.

出版信息

PLoS One. 2013 Aug 20;8(8):e72337. doi: 10.1371/journal.pone.0072337. eCollection 2013.

DOI:10.1371/journal.pone.0072337
PMID:23977282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3748067/
Abstract

Osteogenesis imperfecta (OI) type V is an autosomal-dominant disease characterized by calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation. The causative mutation, c.-14C>T in the 5'-untranslated region of IFITM5, was recently discovered to be involved in this disease. However, in spite of the little genotypic variability, considerable phenotypic variability has been recognized in two cohorts of patients, the majority of whom were Caucasians. Using exome sequencing, we identified the same heterozygous mutation in four Chinese families with OI type V. This study confirms the molecular cause of OI type V and describes the phenotype of Chinese patients with this disorder. In conclusion, the phenotype of Chinese patients was generally similar to that of Caucasian patients.

摘要

Ⅴ型成骨不全症(OI)是一种常染色体显性疾病,其特征为前臂骨间膜钙化、桡骨头脱位、骨骺下干骺端致密线以及增生性骨痂形成。最近发现,IFITM5基因5'-非翻译区的致病突变c.-14C>T与该疾病有关。然而,尽管基因型变异性较小,但在两组患者(其中大多数为白种人)中已认识到存在相当大的表型变异性。通过外显子组测序,我们在四个患有Ⅴ型OI的中国家庭中鉴定出相同的杂合突变。本研究证实了Ⅴ型OI的分子病因,并描述了中国该疾病患者的表型。总之,中国患者的表型与白种人患者总体相似。

相似文献

1
Phenotype and genotype analysis of Chinese patients with osteogenesis imperfecta type V.中国V型成骨不全症患者的表型和基因型分析
PLoS One. 2013 Aug 20;8(8):e72337. doi: 10.1371/journal.pone.0072337. eCollection 2013.
2
A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.IFITM5 5'-UTR 中的单个反复突变导致成骨不全症 V 型。
Am J Hum Genet. 2012 Aug 10;91(2):343-8. doi: 10.1016/j.ajhg.2012.06.005. Epub 2012 Aug 2.
3
IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients.IFITM5 致病变异导致乌克兰和越南患者的成骨不全 V 型,其表型严重程度不同。
Hum Genomics. 2019 Jun 3;13(1):25. doi: 10.1186/s40246-019-0209-3.
4
Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation.由 IFITM5 突变引起的成骨不全症 V 型的表型变异。
J Bone Miner Res. 2013 Jul;28(7):1523-30. doi: 10.1002/jbmr.1891.
5
Two mutations in IFITM5 causing distinct forms of osteogenesis imperfecta.IFITM5基因中的两个突变导致不同形式的成骨不全症。
Am J Med Genet A. 2014 May;164A(5):1136-42. doi: 10.1002/ajmg.a.36409. Epub 2014 Jan 29.
6
Genotype-phenotype study in type V osteogenesis imperfecta.V型成骨不全症的基因型-表型研究
Clin Dysmorphol. 2013 Jul;22(3):93-101. doi: 10.1097/MCD.0b013e32836032f0.
7
The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V.IFITM5基因的c.-14C>T突变导致在人骨中表达的转录本延长;并引起V型成骨不全症不同程度的表型严重程度。
BMC Musculoskelet Disord. 2014 Mar 27;15:107. doi: 10.1186/1471-2474-15-107.
8
Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.由 IFITM5 基因突变引起的无 V 型特征的成骨不全症。
J Bone Miner Res. 2013 Nov;28(11):2333-7. doi: 10.1002/jbmr.1983.
9
A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.IFITM5 5'-UTR 中的突变产生一个无义移码并导致常染色体显性遗传性骨发育不全 V 型伴骨痂过度增生。
Am J Hum Genet. 2012 Aug 10;91(2):349-57. doi: 10.1016/j.ajhg.2012.06.011. Epub 2012 Aug 2.
10
Type V osteogenesis imperfecta: a new form of brittle bone disease.V型成骨不全症:一种新型脆性骨病。
J Bone Miner Res. 2000 Sep;15(9):1650-8. doi: 10.1359/jbmr.2000.15.9.1650.

引用本文的文献

1
Genotypic and Phenotypic Characteristics of 29 Patients With Rare Types of Osteogenesis Imperfecta: Average 5 Years of Follow-Up.29例罕见型成骨不全患者的基因型和表型特征:平均5年随访
Front Genet. 2021 Jul 16;12:622078. doi: 10.3389/fgene.2021.622078. eCollection 2021.
2
Case Report: Hyperplastic Callus of the Femur Mimicking Osteosarcoma in Osteogenesis Imperfecta Type V.病例报告:成骨不全症 V 型中股骨的骨样骨痂增生酷似骨肉瘤。
Front Endocrinol (Lausanne). 2021 Apr 15;12:622674. doi: 10.3389/fendo.2021.622674. eCollection 2021.
3
Effect of immunosuppressants on a mouse model of osteogenesis imperfecta type V harboring a heterozygous Ifitm5 c.-14C > T mutation.

本文引用的文献

1
WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.WNT1 突变与中度严重和进行性隐性成骨不全症家族相关。
Am J Hum Genet. 2013 Apr 4;92(4):590-7. doi: 10.1016/j.ajhg.2013.02.009. Epub 2013 Mar 14.
2
Mutations in WNT1 cause different forms of bone fragility.WNT1 基因突变可导致不同形式的骨脆弱症。
Am J Hum Genet. 2013 Apr 4;92(4):565-74. doi: 10.1016/j.ajhg.2013.02.010. Epub 2013 Mar 14.
3
Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation.
免疫抑制剂对携带杂合性 Ifitm5 c.-14C > T 突变的 V 型成骨不全症小鼠模型的影响。
Sci Rep. 2020 Dec 3;10(1):21197. doi: 10.1038/s41598-020-78403-1.
4
Expanding the Clinical Spectrum of Osteogenesis Imperfecta Type V: 13 Additional Patients and Review.扩大Ⅴ型成骨不全症的临床谱:新增13例患者及文献复习
Front Endocrinol (Lausanne). 2019 Jun 12;10:375. doi: 10.3389/fendo.2019.00375. eCollection 2019.
5
IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients.IFITM5 致病变异导致乌克兰和越南患者的成骨不全 V 型,其表型严重程度不同。
Hum Genomics. 2019 Jun 3;13(1):25. doi: 10.1186/s40246-019-0209-3.
6
Novel mutations in the SEC24D gene in Chinese families with autosomal recessive osteogenesis imperfecta.在中国常染色体隐性遗传性成骨不全症家系中发现 SEC24D 基因的新突变。
Osteoporos Int. 2017 Apr;28(4):1473-1480. doi: 10.1007/s00198-016-3866-2. Epub 2016 Dec 10.
7
Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V.成骨不全Ⅴ型的临床与分子特征
Mol Syndromol. 2015 Oct;6(4):164-72. doi: 10.1159/000439506. Epub 2015 Sep 3.
8
IFITM5 mutations and osteogenesis imperfecta.干扰素诱导跨膜蛋白5(IFITM5)突变与成骨不全症
J Bone Miner Metab. 2016 Mar;34(2):123-31. doi: 10.1007/s00774-015-0667-1. Epub 2015 Jun 2.
9
IFITMs restrict the replication of multiple pathogenic viruses.IFITMs 限制多种致病病毒的复制。
J Mol Biol. 2013 Dec 13;425(24):4937-55. doi: 10.1016/j.jmb.2013.09.024. Epub 2013 Sep 25.
由 IFITM5 突变引起的成骨不全症 V 型的表型变异。
J Bone Miner Res. 2013 Jul;28(7):1523-30. doi: 10.1002/jbmr.1891.
4
Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients.成骨不全症 V 型:所有患者均存在 IFITM5 c.-14C>T 突变,但表型变异显著。
J Med Genet. 2013 Jan;50(1):21-4. doi: 10.1136/jmedgenet-2012-101307.
5
A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.IFITM5 5'-UTR 中的突变产生一个无义移码并导致常染色体显性遗传性骨发育不全 V 型伴骨痂过度增生。
Am J Hum Genet. 2012 Aug 10;91(2):349-57. doi: 10.1016/j.ajhg.2012.06.011. Epub 2012 Aug 2.
6
A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.IFITM5 5'-UTR 中的单个反复突变导致成骨不全症 V 型。
Am J Hum Genet. 2012 Aug 10;91(2):343-8. doi: 10.1016/j.ajhg.2012.06.005. Epub 2012 Aug 2.
7
Evolution of vertebrate interferon inducible transmembrane proteins.脊椎动物干扰素诱导跨膜蛋白的进化。
BMC Genomics. 2012 Apr 26;13:155. doi: 10.1186/1471-2164-13-155.
8
Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish.BMP1 功能减弱会影响成骨作用,导致人类和斑马鱼的骨骼脆弱。
Am J Hum Genet. 2012 Apr 6;90(4):661-74. doi: 10.1016/j.ajhg.2012.02.026.
9
Analysis of skeletal dysplasias in the Utah population.犹他州人群骨骼发育不良分析。
Am J Med Genet A. 2012 May;158A(5):1046-54. doi: 10.1002/ajmg.a.35327. Epub 2012 Mar 27.
10
Recent advances in osteogenesis imperfecta.成骨不全症的最新进展。
Calcif Tissue Int. 2012 Jun;90(6):439-49. doi: 10.1007/s00223-012-9588-3. Epub 2012 Mar 27.